Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.
The pharmacokinetic parameters of 16 patients in the intensive care unit, sedated with midazolam, were evaluated. A large variation was observed in the plasma concentration of midazolam and between the plasma concentration of midazolam and its metabolite 1-hydroxymethylmidazolam glucuronide. The plasma albumin concentration governs the volume of distribution of midazolam. Decreased plasma albumin concentration (25 gm/L) results in an increased volume of distribution and a decreased elimination rate of midazolam. The observed plasma concentration ratio between the parent drug and its metabolite 1-hydroxymethylmidazolam glucuronide is governed by the variables of protein binding, the metabolic rate of midazolam, and the renal clearance of the glucuronide metabolite itself (which can be considered as a measure of the kidney function of the patient).
Vree
T B
TB
Department of Clinical Pharmacy, Sint Radboud Hospital, University of Nijmegen, The Netherlands.
Shimoda
M
M
Driessen
J J
JJ
Guelen
P J
PJ
Janssen
T J
TJ
Termond
E F
EF
van Dalen
R
R
Hafkenscheid
J C
JC
Dirksen
M S
MS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003422:Critical Care; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D016018:Least-Squares Analysis; D008297:Male; D008874:Midazolam / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics*; D008875:Middle Aged; D011485:Protein Binding; D012709:Serum Albumin / Q000032:analysis*
D012709:Serum Albumin; C061795:1-hydroxymethylmidazolam glucuronide; D008874:Midazolam